Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jung Sun Yum"'
Autor:
Soo-Kyung Jeong, Su-Jin Ham, Seung-Hee Baek, Eun-Jung Jung, Hyun-Jin Jo, Hye-Ran Cha, Jae-Myun Lee, Byung Cheol Ahn, Jung Sun Yum, Eunyoung Chun
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-10 (2024)
Abstract Herpes zoster (HZ), also known as shingles, is caused by the reactivation of latent varicella-zoster virus (VZV). Decreased VZV-specific T-cell immune responses significantly contribute to the development of HZ. Shingrix is a recombinant zos
Externí odkaz:
https://doaj.org/article/772d4f8c82c64c9794e4d9787774d918
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Toll-like receptors (TLRs) are critical components to stimulate immune responses against various infections. Recently, TLR agonists have emerged as a promising way to activate anti-tumor immunity. L-pampo, a TLR1/2 and TLR3 agonist, induces
Externí odkaz:
https://doaj.org/article/347a5e626d0342cb8338fac9679b85cf
Autor:
Jeong Hun Kim, Won Suk Lee, Seung Joon Lee, Hannah Yang, Hong Jae Chon, Chan Kim, Jin Hyoung Kim, Byung cheol Ahn, Dong Sung Kim, Yoonki Heo, Eun-Jin Go, Jung Sun Yum
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/bbc3b1d7c9054e4a9ae0ea54ffe2e9ef
Autor:
Soo-Kyung Jeong, Yoon-Ki Heo, Jei-Hyun Jeong, Su-Jin Ham, Jung-Sun Yum, Byung-Cheol Ahn, Chang-Seon Song, Eun-Young Chun
Publikováno v:
Vaccines, Vol 9, Iss 9, p 957 (2021)
The development of COVID-19 vaccines is critical in controlling global health issues under the COVID-19 pandemic. The subunit vaccines are the safest and most widely used vaccine platform and highly effective against a multitude of infectious disease
Externí odkaz:
https://doaj.org/article/277c13c23e614357b19be5c68a1da025
Autor:
Sookyung Jeong, Eunyoung Chun, Chang-Seon Song, Yoon-Ki Heo, Byung-Cheol Ahn, Jei-Hyun Jeong, Su-Jin Ham, Jung-Sun Yum
Publikováno v:
Vaccines; Volume 9; Issue 9; Pages: 957
Vaccines, Vol 9, Iss 957, p 957 (2021)
Vaccines
Vaccines, Vol 9, Iss 957, p 957 (2021)
Vaccines
The development of COVID-19 vaccines is critical in controlling global health issues under the COVID-19 pandemic. The subunit vaccines are the safest and most widely used vaccine platform and highly effective against a multitude of infectious disease
Autor:
Won Suk Lee, Dong Sung Kim, Jeong Hun Kim, Yoonki Heo, Hannah Yang, Eun-Jin Go, Jin Hyoung Kim, Seung Joon Lee, Byung Cheol Ahn, Jung Sun Yum, Hong Jae Chon, Chan Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e004799
BackgroundToll-like receptors (TLRs) are critical innate immune sensors that elicit antitumor immune responses in cancer immunotherapy. Although a few TLR agonists have been approved for the treatment of patients with early-stage superficial cancers,
Autor:
Jin Won Huh, M.D., Ph.D., Kyuyoung Song, Ph.D., Hwa Jung Kim, M.D., Ph.D., Jung-Sun Yum, Ph.D., Sang-Bum Hong, M.D., Ph.D., Chae-Man Lim, M.D., Ph.D., Younsuck Koh, M.D., Ph.D.
Publikováno v:
Tuberculosis and Respiratory Diseases, Vol 81, Iss 4, Pp 305-310 (2017)
Tuberculosis and Respiratory Diseases, Vol 81, Iss 4, Pp 305-310 (2018)
Tuberculosis and Respiratory Diseases, Vol 81, Iss 4, Pp 305-310 (2018)
Background Mannose-binding lectin (MBL) deficiency leads to increased susceptibility to infection. We investigated whether serial changes in MBL levels are associated with the prognosis of patients diagnosed with septic shock, and correlated with cyt
Autor:
Dongjun Kim, Junho Park, Jia Pi, Jung Sun Yum, Jaeseung Yoon, Yongsu Jeong, Jeong-Soo Park, Kwanghee Baek, Byung Cheol Ahn, Hong Mo Moon
Publikováno v:
Protein Expression and Purification. 88:1-6
Mannose-binding lectin (MBL) is an important serum protein that functions in the innate immune system and has been considered to have therapeutic potential in MBL replacement therapies for patients with deficient or low levels of MBL. In this study,
Autor:
Sang Jun Ha, Byeong Jae Lee, Bo Ryeong Lee, Jung Sun Yum, Sung Jae Shin, Soo Kyung Jeong, Byung Cheol Ahn
Publikováno v:
Scientific Reports
SCIENTIFIC REPORTS(6)
SCIENTIFIC REPORTS(6)
Despite the possibility of combining Toll-like receptor (TLR) ligands as adjuvants to improve vaccine efficacy, it remains unclear which combinations of TLR ligands are effective or what their underlying mechanisms may be. Here, we investigated the m
Autor:
John D. Morrey, Young Chul Sung, Hyo Sun Kim, Jung Sun Yum, Jaeseung Yoon, Byung Cheol Ahn, Ki-Hyun Kim, Hyun Jin Jo, Dong Yeon Kim, Hong Mo Moon
Publikováno v:
Clinical and Vaccine Immunology. 19:120-127
A hepatitis B virus (HBV) vaccine has been developed using a new adjuvant and HBV surface antigens produced from a CHO cell line. The purified HBV surface antigens are composed of L protein, M protein, and S protein in a mixture of 20- and 40-nm-diam